Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-IgG)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-IgG) (CAT#: BSSG-394)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-HER2 antibody variable domain are respectively connected to the N terminus of the anti-CD64 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (VHH-IgG) (BSSG-394). Click the button below to contact us or submit your feedback about this product.